Systematic evidence analysis for the transition from relapsing to secondary progressive Multiple Sclerosis in adults

被引：0
|
作者：
Badgujar, L. [1 ]
Khurana, V. [1 ]
Malepati, A. [1 ]
Meier, D. Piani [2 ]
Adlard, N. [2 ]
机构：
[1] Novartis Healthcare Pvt Ltd, Hyderabad, Telangana, India
[2] Novartis Pharma AG, Basel, Switzerland
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2019年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO1208
引用
收藏
页码：471 / 472
页数：2
相关论文
共 50 条
  • [41] Safety of ocrelizumab in multiple sclerosis: Updated analysis in patients with relapsing and primary progressive multiple sclerosis
    Hauser, Stephen L.
    Kappos, Ludwig
    Montalban, Xavier
    Guittari, Carol-Jean
    Koendgen, Harold
    Li, Carrie
    Marcillat, Carole
    Wormser, David
    Wolinsky, Jerry
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (02) : NP13 - NP13
  • [42] Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis
    Hauser, S. L.
    Kappos, L.
    Montalban, X.
    Hughes, R.
    McNamara, J.
    Pradhan, A.
    Wormser, D.
    Koendgen, H.
    Wolinsky, J. S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 239 - 239
  • [43] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis
    Hauser, Stephen L.
    Kappos, Ludwig
    Montalban, Xavier
    Craveiro, Licinio
    Hughes, Richard
    Prajapati, Kalpesh
    Koendgen, Harold
    Pradhan, Ashish
    Wolinsky, Jerry S.
    NEUROLOGY, 2020, 94 (15)
  • [44] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis
    Hauser, S. L.
    Kappos, L.
    Montalban, X.
    Craveiro, L.
    Hughes, R.
    Prajapati, K.
    Koendgen, H.
    Pradhan, A.
    Wolinsky, J. S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 331 - 331
  • [45] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients with Relapsing and Primary Progressive Multiple Sclerosis
    Kappos, Ludwig
    Hauser, Stephen
    Montalban, Xavier
    Buffels, Regine
    Chin, Peter
    Li, Carrie
    Mortensen, Deborah
    Napieralski, Julie
    Van Beek, Johan
    Wormser, David
    Wolinsky, Jerry
    NEUROLOGY, 2017, 88
  • [46] Safety of ocrelizumab in multiple sclerosis: Updated analysis in patients with relapsing and primary progressive multiple sclerosis
    Hauser, S.
    Kappos, L.
    Montalban, X.
    Craveiro, L.
    Hughes, R.
    McNamara, J.
    Pradhan, A.
    Wormser, D.
    Koendgen, H.
    Wolinsky, J. S.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [47] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis
    Hauser, Stephen L.
    Kappos, Ludwig
    Montalban, Xavier
    Hughes, Richard
    McNamara, John
    Pradhan, Ashish
    Wormser, David
    Koendgen, Harold
    Wolinsky, Jerry S.
    NEUROLOGY, 2019, 92 (15)
  • [48] Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis
    Hauser, S. L.
    Kappos, L.
    Montalban, X.
    Hughes, R.
    Koendgen, H.
    McNamara, J.
    Pradhan, A.
    Wormser, D.
    Wolinsky, J. S.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 697 - 698
  • [49] Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis
    Hauser, S. L.
    Kappos, L.
    Montalban, X.
    Chognot, C.
    Jessop, N.
    Pradhan, A.
    Prajapati, K.
    Wolinsky, J. S.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 607 - 608
  • [50] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis
    Hauser, Stephen
    Kappos, Ludwig
    Montalban, Xavier
    Koendgen, Harold
    Li, Carrie
    Marcillat, Carole
    Pradhan, Ashish
    Wormser, David
    Wolinsky, Jerry
    NEUROLOGY, 2018, 90
12345